News und Analysen
GEVELOT S.A.: Weekly report of share buyback November 14, 2022
Transgene and BioInvent Joint Paper on BT-001 Wins JITC “Best Oncolytic and Local Immunotherapy Paper” Award for 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2022
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Poxel Announces Upcoming Participation at the Jefferies London Healthcare Conference
POXEL SA (Euronext: POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
GEVELOT S.A.: Weekly report of share buyback November 7, 2022
Transgene Reports Business Update And Q3 2022 Financial Position
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announces its business
Transgene Announces Positive Interim Analysis Results of Phase II Trial Evaluating TG4001 + Avelumab vs Avelumab in HPV-Positive Anogenital Cancers
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that following an interim analysis of
GEVELOT S.A.: Weekly report of share buyback October 31, 2022
Axway Software: 2022 Strategic Portfolio Refocusing Objective Achieved
Regulatory News:
Axway (Paris:AXW) today announces that it has achieved its 2022 objective to rationalize its product portfolio thanks to several operations carried out in recent months. In line
Axway Software: Q3 2022 revenue of €67.5m, ARR up 6.6%
Regulatory News:
During the first 9 months of the year, Axway (Euronext: AXW.PA) (Paris:AXW) confirmed the ramp-up of its cloud-based subscription offerings. This trend, which impacts the
Voyageurs du Monde: Business picking up significantly
Kaufman & Broad SA: AUSTERLITZ STATION PROJECT THE BUILDING PERMIT PURGED OF ALL RECOURSES FOLLOWING THE REJECTION BY THE “CONSEIL D’ETAT” OF THE APPEAL
Pakistanischer Anbieter von digitalen Geldbörsen und Debitkarten nutzt erweitere Abwehrtechnologien (XTD) von Verimatrix zur Stärkung seiner Sicherheitsposition
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass SadaPay, ein pakistanischer
Pakistani Digital Wallet and Debit Card Provider Deploys Verimatrix Extended Threat Defense Technologies to Bolster Security Posture
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Pakistini digital wallet
Poxel Announces Upcoming Presentation at the H.C. Wainwright 6th Annual NASH Investor Virtual Conference
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Kaufman & Broad SA: capital increase offer reserved for employees 'KB Shares 2022'
Poxel to Present DESTINY-1 Phase 2 Results for PXL065 in NASH at AASLD The Liver Meeting® 2022
POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including
Verimatrix beim Gartner® Hype Cycle™ für Anwendungssicherheit 2022 als „Sample Vendor“ ausgezeichnet
Verimatrix, (Euronext Paris: VMX) (Paris: VMX), der führende Anbieter von kundenorientierten Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen im Bericht
Verimatrix Recognized as a Sample Vendor in 2022 Gartner® Hype Cycle™ for Application Security
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced it has been identified as a Sample
EQS-News: Abivax: first US patient enrolled in global phase 3 program with obefazimod in ulcerative colitis
Nanobiotix: Voting Rights and Shares Capital of the Company
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
PATRIMOINE ET COMMERCE: Q3 2022 RESULTS +7,3% IN GROSS RENTAL INCOME AT €35.3M